Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: A TMS study - PubMed (original) (raw)
. 2016 Aug;127(8):2713-2719.
doi: 10.1016/j.clinph.2016.05.003. Epub 2016 May 20.
Affiliations
- PMID: 27417041
- DOI: 10.1016/j.clinph.2016.05.003
Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: A TMS study
Luis Velázquez-Pérez et al. Clin Neurophysiol. 2016 Aug.
Abstract
Objective: To evaluate if the corticospinal tract is affected in the prodromal stage of spinocerebellar ataxia type 2 (SCA2), prior to development of the cerebellar syndrome.
Methods: A cross-sectional study was conducted in 37 non-ataxic SCA2 mutation carriers and in age- and sex-matched healthy controls. All subjects underwent clinical assessment and transcranial magnetic stimulation to determine corticospinal tract integrity to the right abductor pollicis brevis and tibialis anterior muscles.
Results: Non-ataxic SCA2 mutation carriers showed significantly higher resting and active motor thresholds for both muscles, and prolonged cortical silent periods and central motor conduction times (CMCT), compared to controls. CMCT to the tibialis anterior correlated directly with CAG repeat size, and inversely with predicted time to ataxia onset.
Conclusion: Findings provide novel electrophysiological evidence for affection of the corticospinal tract and motor cortex in prodromal SCA2. Slowed conduction in the corticospinal tract to the lower limbs reflects polyglutamine neurotoxicity, and predicts time to ataxia onset.
Significance: Identification of corticospinal tract damage and decreases motor cortical excitability in the prodromal stage of SCA2 allows early disease monitoring. This will become important as soon as effective neuroprotective treatment will be available.
Keywords: Corticospinal tract; Motor cortex; Motor evoked potentials; Prodromal disease stage; Spinocerebellar ataxia type 2; Transcranial magnetic stimulation.
Copyright © 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2.
Velázquez-Pérez L, Tünnerhoff J, Rodríguez-Labrada R, Torres-Vega R, Belardinelli P, Medrano-Montero J, Peña-Acosta A, Canales-Ochoa N, Vázquez-Mojena Y, González-Zaldivar Y, Auburger G, Ziemann U. Velázquez-Pérez L, et al. Cerebellum. 2017 Apr;16(2):602-606. doi: 10.1007/s12311-016-0827-4. Cerebellum. 2017. PMID: 27730516 - Progression of corticospinal tract dysfunction in pre-ataxic spinocerebellar ataxia type 2: A two-years follow-up TMS study.
Velázquez-Pérez L, Rodríguez-Labrada R, Torres-Vega R, Ortega-Sánchez R, Medrano-Montero J, González-Piña R, Vázquez-Mojena Y, Auburger G, Ziemann U. Velázquez-Pérez L, et al. Clin Neurophysiol. 2018 May;129(5):895-900. doi: 10.1016/j.clinph.2018.01.066. Epub 2018 Mar 15. Clin Neurophysiol. 2018. PMID: 29550649 - Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2).
Restivo DA, Giuffrida S, Rapisarda G, Antonuzzo A, Saponara R, Reggio A, Trovato Salinaro A, Raffaele R, Domina E, Trovato A, Condorelli DF, Pennisi G. Restivo DA, et al. Clin Neurophysiol. 2000 Apr;111(4):630-5. doi: 10.1016/s1388-2457(99)00305-3. Clin Neurophysiol. 2000. PMID: 10727914 - Central motor conduction time.
Udupa K, Chen R. Udupa K, et al. Handb Clin Neurol. 2013;116:375-86. doi: 10.1016/B978-0-444-53497-2.00031-0. Handb Clin Neurol. 2013. PMID: 24112910 Review. - Investigating human motor control by transcranial magnetic stimulation.
Petersen NT, Pyndt HS, Nielsen JB. Petersen NT, et al. Exp Brain Res. 2003 Sep;152(1):1-16. doi: 10.1007/s00221-003-1537-y. Epub 2003 Jul 17. Exp Brain Res. 2003. PMID: 12879177 Review.
Cited by
- Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2.
Velázquez-Pérez L, Tünnerhoff J, Rodríguez-Labrada R, Torres-Vega R, Belardinelli P, Medrano-Montero J, Peña-Acosta A, Canales-Ochoa N, Vázquez-Mojena Y, González-Zaldivar Y, Auburger G, Ziemann U. Velázquez-Pérez L, et al. Cerebellum. 2017 Apr;16(2):602-606. doi: 10.1007/s12311-016-0827-4. Cerebellum. 2017. PMID: 27730516 - Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.
Ilg W, Branscheidt M, Butala A, Celnik P, de Paola L, Horak FB, Schöls L, Teive HAG, Vogel AP, Zee DS, Timmann D. Ilg W, et al. Cerebellum. 2018 Oct;17(5):628-653. doi: 10.1007/s12311-018-0937-2. Cerebellum. 2018. PMID: 29656311 Review. - Clinical, Imaging, and Laboratory Markers of Premanifest Spinocerebellar Ataxia 1, 2, 3, and 6: A Systematic Review.
Kim DH, Kim R, Lee JY, Lee KM. Kim DH, et al. J Clin Neurol. 2021 Apr;17(2):187-199. doi: 10.3988/jcn.2021.17.2.187. J Clin Neurol. 2021. PMID: 33835738 Free PMC article. Review. - Central motor conduction time in spinocerebellar ataxia: a meta-analysis.
Tang ZC, Chen Z, Shi YT, Wan LL, Liu MJ, Hou X, Wang CR, Peng HR, Peng LL, Qiu R, Tang BS, Jiang H. Tang ZC, et al. Aging (Albany NY). 2020 Nov 20;12(24):25718-25729. doi: 10.18632/aging.104181. Epub 2020 Nov 20. Aging (Albany NY). 2020. PMID: 33232267 Free PMC article. - In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
Sen NE, Arsovic A, Meierhofer D, Brodesser S, Oberschmidt C, Canet-Pons J, Kaya ZE, Halbach MV, Gispert S, Sandhoff K, Auburger G. Sen NE, et al. Int J Mol Sci. 2019 Nov 21;20(23):5854. doi: 10.3390/ijms20235854. Int J Mol Sci. 2019. PMID: 31766565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials